Terms: = Prostate cancer AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4 AND Treatment
15955 results:
1. Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values.
Rogic I; Golubic AT; Zuvic M; Smitran T; Jukic N; Gamulin M; Kastelan Z; Huic D
Nucl Med Rev Cent East Eur; 2024; 27(0):6-12. PubMed ID: 38680016
[TBL] [Abstract] [Full Text] [Related]
2. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Carmignani L; De Cobelli O; Mischinger J; Ahyai S; Karakiewicz PI
World J Urol; 2024 Apr; 42(1):269. PubMed ID: 38679642
[TBL] [Abstract] [Full Text] [Related]
3. Salvage Radiotherapy PSMA PET/CT-guided in Men With PSA Recurrence.
Tamburo M; Buffettino E; Pepe P; Marletta G; Pepe L; Cosentino S; Ippolito M; Pennisi M; Marletta F
Anticancer Res; 2024 May; 44(5):2205-2210. PubMed ID: 38677723
[TBL] [Abstract] [Full Text] [Related]
4. treatment of Osteoporosis in Men on Androgen Deprivation Therapy in Japan.
Nishimoto H; Inui A; Mifune Y; Yamaura K; Bando Y; Okamura Y; Hara T; Terakawa T; Kuroda R
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674197
[No Abstract] [Full Text] [Related]
5. Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant prostate cancer.
Turnham DJ; Mullen MS; Bullock NP; Gilroy KL; Richards AE; Patel R; Quintela M; Meniel VS; Seaton G; Kynaston H; Clarkson RWE; Phesse TJ; Nelson PS; Haffner MC; Staffurth JN; Pearson HB
Cells; 2024 Apr; 13(8):. PubMed ID: 38667288
[TBL] [Abstract] [Full Text] [Related]
6. Cotrimoxazole and targeted antibiotic prophylaxis for transrectal prostate biopsy: a single-center study.
Jahnen M; Amiel T; Kirchoff F; Büchler JW; Herkommer K; Rothe K; Meissner VH; Gschwend JE; Lunger L
World J Urol; 2024 Apr; 42(1):260. PubMed ID: 38664275
[TBL] [Abstract] [Full Text] [Related]
7. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
8. Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [
Arbuznikova D; Klotsotyra A; Uhlmann L; Domogalla LC; Steinacker N; Mix M; Niedermann G; Spohn SKB; Freitag MT; Grosu AL; Meyer PT; Gratzke C; Eder M; Zamboglou C; Eder AC
Theranostics; 2024; 14(6):2560-2572. PubMed ID: 38646643
[TBL] [Abstract] [Full Text] [Related]
9. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
[No Abstract] [Full Text] [Related]
10. Surgical management of rectal cancer with synchronous treatment of prostate cancer.
Brière R; Martin AG; Letarte F; Fournier FR; Bouchard P; Drolet S
Langenbecks Arch Surg; 2024 Apr; 409(1):133. PubMed ID: 38642125
[TBL] [Abstract] [Full Text] [Related]
11. [LncRNA RPL22P1-201 affects prostate cancer cell proliferation, cell cycle, and sensitivity to docetaxel by regulating miR-216b-5p expression].
Yang C; Xue JG
Zhonghua Nan Ke Xue; 2023 Oct; 29(10):881-887. PubMed ID: 38639656
[TBL] [Abstract] [Full Text] [Related]
12. [Application of 1470 nm semiconductor laser in the treatment of benign prostatic hyperplasia in ultra-aged patients].
Wu D; Yi XM; Wei HX; Zhang KX; Shi CJ; Shi XQ; Xu ZY; Fu D
Zhonghua Nan Ke Xue; 2023 Sep; 29(9):831-836. PubMed ID: 38639597
[TBL] [Abstract] [Full Text] [Related]
13. Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy.
Rodler S; Danninger D; Eismann L; Kazmierczak PM; Jokisch F; Li M; Becker A; Kretschmer A; Stief C; Westhofen T
World J Urol; 2024 Apr; 42(1):242. PubMed ID: 38635030
[TBL] [Abstract] [Full Text] [Related]
14. A pictorial view on false positive findings of
Dancheva Z; Chausheva S; Stoeva T; Dyankova M; Yordanova T; Chaushev B; Marinov R; Nikolov V; Abushev P; Todorov G; Dimitrova E; Klisarova A; Anakievski D
Hell J Nucl Med; 2024; 27(1):16-26. PubMed ID: 38629815
[TBL] [Abstract] [Full Text] [Related]
15. Supported exercise TrAining for Men wIth prostate cancer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation.
McNaught E; Reale S; Bourke L; Brown JE; Collinson M; Day F; Hewison J; Farrin AJ; Ibeggazene S; Innes AQ; Mason E; Meads D; Scope A; Taylor C; Taylor SJ; Turner RR; Rosario DJ;
Trials; 2024 Apr; 25(1):257. PubMed ID: 38610058
[TBL] [Abstract] [Full Text] [Related]
16. Radiopharmaceutical transport in solid tumors via a 3-dimensional image-based spatiotemporal model.
Piranfar A; Moradi Kashkooli F; Zhan W; Bhandari A; Saboury B; Rahmim A; Soltani M
NPJ Syst Biol Appl; 2024 Apr; 10(1):39. PubMed ID: 38609421
[TBL] [Abstract] [Full Text] [Related]
17. Advantage of whole-mount histopathology in prostate cancer: current applications and future prospects.
Duan L; Liu Z; Wan F; Dai B
BMC Cancer; 2024 Apr; 24(1):448. PubMed ID: 38605339
[TBL] [Abstract] [Full Text] [Related]
18. [Mechanism study on the effect of androgen antagonism in prostate cancer].
Song X; Song Q; Wang R; Zuo QJ; Zhang ZY
Zhonghua Nan Ke Xue; 2023 May; 29(5):402-408. PubMed ID: 38602755
[TBL] [Abstract] [Full Text] [Related]
19. Predictors of postoperative storage symptoms in male patients with lower urinary tract symptoms: A retrospective analysis of prostate surgery for benign prostatic enlargement.
Ito H; Takanashi M; Fukazawa T; Takizawa H; Hioki M; Shinoki R; Kawahara T; Makiyama K; Kobayashi K
Low Urin Tract Symptoms; 2024 May; 16(3):e12512. PubMed ID: 38602061
[TBL] [Abstract] [Full Text] [Related]
20. Clinical safety and efficacy of microwave ablation for small renal masses.
Foret A; Haaga CB; Jain S; Baumgartner CO; Escott M; Henderson BR; O'Brien ST; Delacroix SE; Gills JRR; Westerman ME
Int Braz J Urol; 2024; 50(3):277-286. PubMed ID: 38598830
[TBL] [Abstract] [Full Text] [Related]
[Next]
